<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36543746</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-313X</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>International journal of immunogenetics</Title><ISOAbbreviation>Int J Immunogenet</ISOAbbreviation></Journal><ArticleTitle>Association of class II HLA alleles with susceptibility to develop immune-mediated diseases in Paraguayan patients.</ArticleTitle><Pagination><StartPage>12</StartPage><EndPage>18</EndPage><MedlinePgn>12-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/iji.12609</ELocationID><Abstract><AbstractText>Genetic and nongenetic factors are involved in the pathogenesis of immune-mediated inflammatory diseases (IMIDs). The best-known genetic factor for susceptibility to IMIDs is the human leukocyte antigen (HLA). The aim of the present study was to evaluate the association of HLA class II genes with the risk of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (SSc) in the Paraguayan population. We included 254 patients with IMIDs (101 SLE, 103 RA, and 50 SSc) and 50 healthy controls. The haplotypes of five genes corresponding to HLA class II genes and their relationship to the IMIDs studied were determined. Note that 84.6% were women, with a mean age of 43.4 &#xb1; 14 years. Among the associated HLA alleles, we found the previously identified risk factors in other populations like HLA-DRB1*03:01 and HLA-DRB1*14:02 for RA, as well as new ones not previously identified, such as DPA1*02:01 for SLE and, DB1*02:01 for RA and SSc. In the genetic association analysis, already known associations have been replicated, and unpublished associations have been identified in Paraguayan patients with IMIDs. This is the first genetic association study in Paraguayan patients with IMIDs.</AbstractText><CopyrightInformation>&#xa9; 2022 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Acosta-Colman</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-7296-5950</Identifier><AffiliationInfo><Affiliation>Departamento de Reumatolog&#xed;a, Facultad de Ciencias M&#xe9;dicas, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera-Villalba</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6224-2679</Identifier><AffiliationInfo><Affiliation>Departamento de Reumatolog&#xed;a, Facultad de Ciencias M&#xe9;dicas, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayala-Lugo</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5844-1445</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Ciencias de la Salud, Laboratorio de Gen&#xe9;tica Molecular, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jolly</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-8249-5374</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Ciencias de la Salud, Laboratorio de Gen&#xe9;tica Molecular, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vazquez</LastName><ForeName>Marcos</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2623-0050</Identifier><AffiliationInfo><Affiliation>Departamento de Reumatolog&#xed;a, Facultad de Ciencias M&#xe9;dicas, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morel</LastName><ForeName>Zoilo</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-6438-446X</Identifier><AffiliationInfo><Affiliation>Departamento de Reumatolog&#xed;a, Facultad de Ciencias M&#xe9;dicas, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langjahr</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9793-3373</Identifier><AffiliationInfo><Affiliation>Facultad de Ciencias Qu&#xed;micas, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7130-3717</Identifier><AffiliationInfo><Affiliation>Departamento de Reumatolog&#xed;a, Facultad de Ciencias M&#xe9;dicas, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarate</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8024-021X</Identifier><AffiliationInfo><Affiliation>Laboratorio Curie, Asunci&#xf3;n, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acosta</LastName><ForeName>Maria Eugenia</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-0801-4397</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Ciencias de la Salud, Laboratorio de Gen&#xe9;tica Molecular, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avila-Pedretti</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-6526-6278</Identifier><AffiliationInfo><Affiliation>Departamento de Reumatolog&#xed;a, Facultad de Ciencias M&#xe9;dicas, Universidad Nacional de Asunci&#xf3;n, San Lorenzo, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juli&#xe0;</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6064-3620</Identifier><AffiliationInfo><Affiliation>Group de Recerca en Reumatologia, Institut de Recerca Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Mar&#xed;a Teresa</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0002-0024-4596</Identifier><AffiliationInfo><Affiliation>Laboratorio Curie, Asunci&#xf3;n, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsal</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5515-3854</Identifier><AffiliationInfo><Affiliation>Group de Recerca en Reumatologia, Institut de Recerca Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>14-INV-039</GrantID><Agency>This project was co-financed by the Consejo Nacional de Ciencia y Tecnolog&#xed;a (CONACYT) with the support of the FEEI</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Immunogenet</MedlineTA><NlmUniqueID>101232337</NlmUniqueID><ISSNLinking>1744-3121</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000091369">Immunomodulating Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091369" MajorTopicYN="N">Immunomodulating Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">human leukocyte antigen (HLA)</Keyword><Keyword MajorTopicYN="N">major histocompatibility complex (MHC)</Keyword><Keyword MajorTopicYN="N">paraguayans</Keyword><Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">systemic sclerosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>22</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36543746</ArticleId><ArticleId IdType="doi">10.1111/iji.12609</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Achour, Y., Ben Hamad, M., Chaabane, S., Rebai, A., Marzouk, S., Mahfoudh, N., Bahloul, Z., Keskes, L., &amp; Maalej, A. (2017). Analysis of two susceptibility SNPs in HLA region and evidence of interaction between rs6457617 in HLA-DQB1 and HLA-DRB1*04 locus on Tunisian rheumatoid arthritis. Journal of Genetics, 96(6), 911-918. https://doi.org/10.1007/s12041-017-0855-y</Citation></Reference><Reference><Citation>Agarwal, S. K., &amp; Reveille, J. D. (2010). The genetics of scleroderma (systemic sclerosis). Current Opinion in Rheumatology, 22(2), 133-138. https://doi.org/10.1097/BOR.0b013e3283367c17</Citation></Reference><Reference><Citation>Alarc&#xf3;n-Riquelme, M. E., Ziegler, J. T., Molineros, J., Howard, T. D., Moreno-Estrada, A., S&#xe1;nchez-Rodr&#xed;guez, E., Ainsworth, H. C., Ortiz-Tello, P., Comeau, M. E., Rasmussen, A., Kelly, J. A., Adler, A., Acevedo-V&#xe1;Zquez, E. M., Mariano Cucho-Venegas, J., Garc&#xed;a&#xad;A-De La Torre, I., Cardiel, M. H., Miranda, P., Catoggio, L. J., &amp; &#x2026; Jacob, C. O. (2016). Genome-wide association study in an Amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of European admixture. Arthritis &amp; Rheumatology, 68(4), 932-943. https://doi.org/10.1002/art.39504</Citation></Reference><Reference><Citation>Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O. 3rd, Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., Combe, B., Costenbader, K. H., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M. W., Hobbs, K., Huizinga, T. W. J., Kavanaugh, A., &amp; &#x2026; Hawker, G. (2010). 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism, 62(9), 2569-2581. https://doi.org/10.1002/art.27584</Citation></Reference><Reference><Citation>Anukul, N., Pathanapitoon, K., Leetrakool, N., Guntiya, T., Wita, R., Palacajornsuk, P., &amp; Klangsinsirikul, P. (2021). HLA-DRB1*04:05 and HLA-DQB1*04:01: Alleles potentially associated with Vogt-Koyanagi-Harada in northern Thai patients. Ocular Immunology and Inflammation, 29(2), 260-263. https://doi.org/10.1080/09273948.2020.1813315</Citation></Reference><Reference><Citation>Arias, M. V. A., Domingues, E. V., Lozano, R. B., Flores, C. V., Peralta, M. M., &amp; Salinas, C. Z. (2010). Study of class I and II HLA alleles in 30 Ecuadorian patients with rheumatoid arthritis compared with alleles from healthy and affected subjects with other rheumatic diseases. Revista Brasileira Reumatologia, 50(4), 423-427.</Citation></Reference><Reference><Citation>Arnett, F. C., Gourh, P., Shete, S., Ahn, C. W., Honey, R. E., Agarwal, S. K., Tan, F. K., McNearney, T., Fischbach, M., Fritzler, M. J., Mayes, M. D., &amp; Reveille, J. D. (2010). Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: Analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Annals of the Rheumatic Diseases, 69(5), 822-827. https://doi.org/10.1136/ard.2009.111906</Citation></Reference><Reference><Citation>Arora-Singh, R. K., Assassi, S., del Junco, D. J., Arnett, F. C., Perry, M., Irfan, U., Sharif, R., Mattar, T., &amp; Mayes, M. D. (2010). Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. Journal of Autoimmunity, 35(1), 52-57. https://doi.org/10.1016/j.jaut.2010.02.001</Citation></Reference><Reference><Citation>Balbir-Gurman, A., Shataylo, V., &amp; Braun-Moscovici, Y. (2019). Autoimmune diseases in systemic sclerosis patients and their relatives: Data from a single center. The Israel Medical Association Journal, 21(1), 29-34.</Citation></Reference><Reference><Citation>Calvo-Al&#xe9;n, J., Reveille, J. D., Rodr&#xed;guez-Valverde, V., McGwin, G., Baethge, B. A., Friedman, A. W., Friedman, A. W., &amp; Alarc&#xf3;n, G. S. (2003). Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus, 12(5), 377-385. https://doi.org/10.1191/0961203303lu372oa</Citation></Reference><Reference><Citation>Castro, F., Acevedo, E., Ciusani, E., Angulo, J. A., Wollheim, F. A., &amp; Sandberg-Wollheim, M. (2001). Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 60(8), 791-795. https://doi.org/10.1136/ard.60.8.791</Citation></Reference><Reference><Citation>Chen, Z., Lan, R., Ye, K., Chen, H., Chen, C., &amp; Xu, Y. (2021). Prioritization of diagnostic and prognostic biomarkers for lupus nephritis based on integrated bioinformatics analyses. Frontiers in Bioengineering and Biotechnology, 9, 717234. https://doi.org/10.3389/fbioe.2021.717234</Citation></Reference><Reference><Citation>Cortes, L. M., Baltazar, L. M., Lopez-Cardona, M. G., Olivares, N., Ramos, C., Salazar, M., Sandoval, L., Lorenz, M. G. O., Chakraborty, R., Paterson, A. D., &amp; Rivas, F. (2004). HLA class II haplotypes in Mexican systemic lupus erythematosus patients. Human Immunology, 65(12), 1469-1476. https://doi.org/10.1016/j.humimm.2004.09.008</Citation></Reference><Reference><Citation>Cotsapas, C., Voight, B. F., Rossin, E., Lage, K., Neale, B. M., Wallace, C., Abecasis, G. A. R., Barrett, J. C., Behrens, T., Cho, J., De Jager, P. L., Elder, J. T., Graham, R. R., Gregersen, P., Klareskog, L., Siminovitch, K. A., Van Heel, D. A., Wijmenga, C., Worthington, J., &amp; &#x2026; Daly, M. J. (2011). Pervasive sharing of genetic effects in autoimmune disease. PLoS Genetics, 7(8), e1002254. https://doi.org/10.1371/journal.pgen.1002254</Citation></Reference><Reference><Citation>Cruz-Tapias, P., P&#xe9;rez-Fern&#xe1;ndez, O. M., Rojas-Villarraga, A., Rodr&#xed;guez-Rodr&#xed;guez, A., Arango, M. T., &amp; Anaya, J. M. (2012). Shared HLA class II in six autoimmune diseases in Latin America: A meta-analysis. Autoimmune Diseases, 2012, 569728. https://doi.org/10.1155/2012/569728</Citation></Reference><Reference><Citation>Deane, K. D., Demoruelle, M. K., Kelmenson, L. B., Kuhn, K. A., Norris, J. M., &amp; Holers, V. M. (2017). Genetic and environmental risk factors for rheumatoid arthritis. Best Practice &amp; Research Clinical Rheumatology, 31(1), 3-18. https://doi.org/10.1016/j.berh.2017.08.003</Citation></Reference><Reference><Citation>du Montcel, S. T., Michou, L., Petit-Teixeira, E., Osorio, J., Lemaire, I., Lasbleiz, S., Pierlot, C., Quillet, P., Bardin, T., Prum, B., Cornelis, F., &amp; Clerget-Darpoux, F. (2005). New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis and Rheumatism, 52(4), 1063-1068. https://doi.org/10.1002/art.20989</Citation></Reference><Reference><Citation>Garcia-Silva, R., Hernandez-Do&#xf1;o, S., Rom&#xe1;n-Amparo, J. P., Trujillo-Vizuet, M. G., Mena-Vela, B. A., Rizo-Pinto, A., Tirado, J. M. P., Cetina-D&#xed;az, J. H., Bulos-Rodr&#xed;guez, P., Granados, J., &amp; Sep&#xfa;lveda-Delgado, J. (2021). Mayan alleles of the HLA-DRB1 major histocompatibility complex might contribute to the genetic susceptibility to systemic lupus erythematosus in Mexican patients from Tapachula, Chiapas. Clinical Rheumatology, 40(8), 3095-3103. https://doi.org/10.1007/s10067-021-05636-4</Citation></Reference><Reference><Citation>Ghodke-Puranik, Y., &amp; Niewold, T. B. (2015). Immunogenetics of systemic lupus erythematosus: A comprehensive review. Journal of Autoimmunity, 64, 125-136. https://doi.org/10.1016/j.jaut.2015.08.004</Citation></Reference><Reference><Citation>Gough, S. C. L., &amp; Simmonds, M. J. (2007). The HLA region and autoimmune disease: Associations and mechanisms of action. Current Genomics, 8(7), 453-465. https://doi.org/10.2174/138920207783591690</Citation></Reference><Reference><Citation>Hanscombe, K. B., Morris, D. L., Noble, J. A., Dilthey, A. T., Tombleson, P., Kaufman, K. M., Comeau, M., Langefeld, C. D., Alarcon-Riquelme, M. E., Gaffney, P. M., Jacob, C. O., Sivils, K. L., Tsao, B. P., Alarcon, G. S., Brown, E. E., Croker, J., Edberg, J., Gilkeson, G., James, J. A., &amp; &#x2026; Vyse, T. J. (2018). Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans. Human Molecular Genetics, 27(21), 3813-3824. https://doi.org/10.1093/hmg/ddy280</Citation></Reference><Reference><Citation>Hanson, A. L., Sahhar, J., Ngian, G. S., Roddy, J., Walker, J., Stevens, W., Nikpour, M., Assassi, S., Proudman, S., Mayes, M. D., Kenna, T. J., &amp; Brown, M. A. (2022). Contribution of HLA and KIR alleles to systemic sclerosis susceptibility and immunological and clinical disease subtypes. Frontiers in Genetics, 13, 913196. https://doi.org/10.3389/fgene.2022.913196 PMID: 35754823; PMCID: PMC9214260</Citation></Reference><Reference><Citation>Hochberg, M. C. (1997). Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 40(9), 1725.</Citation></Reference><Reference><Citation>Karlson, E. W., Ding, B., Keenan, B. T., Liao, K., Costenbader, K. H., Klareskog, L., Alfredsson, L., &amp; Chibnik, L. B. (2013). Association of environmental and genetic factors and gene-environment interactions with risk of developing rheumatoid arthritis. Arthritis Care Research, 65(7), 1147-1156. https://doi.org/10.1002/acr.22005</Citation></Reference><Reference><Citation>LeRoy, E. C., &amp; Medsger, T. A. Jr. (2001). Criteria for the classification of early systemic sclerosis. Journal of Rheumatology, 28(7), 1573-1576.</Citation></Reference><Reference><Citation>MacGregor, A. J., Snieder, H., Rigby, A. S., Koskenvuo, M., Kaprio, J., Aho, K., &amp; Silman, A. J. (2000). Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis and Rheumatism, 43(1), 30-37. https://doi.org/10.1002/1529-0131(200001)43:1&lt;30::AID-ANR5&gt;3.0.CO;2-B</Citation></Reference><Reference><Citation>Morris, D. L., Taylor, K. E., Fernando, M. M. A., Nititham, J., Alarc&#xf3;n-Riquelme, M. E., Barcellos, L. F., Behrens, T. W., Cotsapas, C., Gaffney, P. M., Graham, R. R., Pons-Estel, B. A., Gregersen, P. K., Harley, J. B., Hauser, S. L., Hom, G., Langefeld, C. D., Noble, J. A., Rioux, J. D., Seldin, M. F., &amp; &#x2026; Vyse, T. J. (2012). Unraveling multiple MHC gene associations with systemic lupus erythematosus: Model choice indicates a role for HLA alleles and non-HLA genes in Europeans. American Journal of Human Genetics, 91(5), 778-793. https://doi.org/10.1016/j.ajhg.2012.08.026</Citation></Reference><Reference><Citation>Petri, M., Orbai, A. M., Alarc&#xf3;n, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Bae, S.-C., Hanly, J. G., S&#xe1;nchez-Guerrero, J., Clarke, A., Aranow, C., Manzi, S., Urowitz, M., &amp; &#x2026; Magder, L. S. (2012). Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis and Rheumatism, 64(8), 2677-2686.</Citation></Reference><Reference><Citation>Rodriguez-Reyna, T. S., Mercado-Vel&#xe1;zquez, P., Yu, N., Alosco, S., Ohashi, M., Lebedeva, T., Cruz-Lagunas, A., N&#xfa;&#xf1;ez-&#xc1;lvarez, C., Cabiedes-Contreras, J., Vargas-Alarc&#xf3;n, G., Granados, J., Z&#xfa;&#xf1;iga, J., &amp; Yunis, E. (2015). HLA class I and II blocks are associated to susceptibility, clinical subtypes and autoantibodies in Mexican systemic sclerosis (SSc) patients. PLoS One, 10(5), e0126727. https://doi.org/10.1371/journal.pone.0126727</Citation></Reference><Reference><Citation>Scally, S. W., Law, S., Ting, Y. T., Van Heemst, J., Deutsch, A. J., Clemens, E. B., Bridie Clemens, E., Moustakas, A. K., Papadopoulos, G. K., Woude, D. V. D., Smolik, I., Hitchon, C. A., Robinson, D. B., Ferucci, E. D., Bernstein, C. N., Meng, X., Anaparti, V., Huizinga, T., Kedzierska, K., &amp; &#x2026; Thomas, R. (2019). Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis. Annals of the Rheumatic Diseases, 76(11), 1915-1923. https://doi.org/10.1136/annrheumdis-2017-211300</Citation></Reference><Reference><Citation>Selvaraja, M., Too, C. L., Tan, L. K., Koay, B. T., Abdullah, M., Shah, A. M., Arip, M., &amp; Amin-Nordin, S. (2022). Human leucocyte antigens profiling in Malay female patients with systemic lupus erythematosus: Are we the same or different? Lupus Science &amp; Medicine, 9(1), e000554. https://doi.org/10.1136/lupus-2021-000554</Citation></Reference><Reference><Citation>Taneja, V., Behrens, M., Mangalam, A., Griffiths, M. M., Luthra, H. S., &amp; David, C. S. (2007). New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis and Rheumatism, 56(1), 69-78. https://doi.org/10.1002/art.22213</Citation></Reference><Reference><Citation>Ting, Y. T., Petersen, J., Ramarathinam, S. H., Scally, S. W., Loh, K. L., Thomas, R., Suri, A., Baker, D. G., Purcell, A. W., Reid, H. H., &amp; Rossjohn, J. (2018). The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis. Journal of Biological Chemistry, 293(9), 3236-3251. https://doi.org/10.1074/jbc.RA117.001013</Citation></Reference><Reference><Citation>Trowsdale, J., &amp; Knight, J. C. (2013). Major histocompatibility complex genomics and human disease. Annual Review of Genomics and Human Genetics, 14(1), 301-323. https://doi.org/10.1146/annurev-genom-091212-153455</Citation></Reference><Reference><Citation>Williams, R. C., Jacobsson, L. T. H., Knowler, W. C., del Puente, A., Kostyu, D., McAuley, J. E., Bennett, P. H., &amp; Pettitt, D. J. (1995). Meta-analysis reveals association between most common class II haplotype in full-heritage native Americans and rheumatoid arthritis. Human Immunology, 42(1), 90-94. https://doi.org/10.1016/0198-8859(94)00079-6</Citation></Reference><Reference><Citation>Zhang, X. Y., Jin, J. Y., He, J., Gan, Y. Z., Chen, J. L., Zhao, X. Z., Liu, J. J., You, X. J., Li, X., Guo, J. P., Li, X. F., Li, J., Li, R., &amp; Li, Z. G. (2019). Family history of rheumatic diseases in patients with rheumatoid arthritis: A large scale cross-sectional study. Beijing Da Xue Xue Bao Yi Xue Ban, 51(3), 439-444. Chinese. https://doi.org/10.19723/j.issn.1671-167X.2019.03.010</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>